SCYXSCYNEXIS, Inc.
What is the market doing?
In a downtrend (−26% vs 200-day). That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
In a downtrend, below its 50- and 200-day averages. Price is −26% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How SCYX is trading
SCYNEXIS, Inc. is −34% over the past year while the S&P 500 is +18%: 52 points behind the market.
1-year return · S&P 500 +18%
- vs 200-day average
- −26%
vs 200-day average · a clear downtrend
- RSI (14)
- 46
RSI (14) · neutral
- Below its 52-week high
- 53%
Below its 52-week high
Details›
- Last close2026-10-08
- $4.19
- 1 monthS&P 500 +1.6%
- −15%
- 1 yearS&P 500 +18%
- −34%
- 5 yearsS&P 500 +86%
- −90%
- vs 50-day average$4.96
- −15%
- 52-week high
- $8.88
- 52-week low
- $3.57
- Annualised volatility
- 79%
| Year | Return |
|---|---|
| 2026 (year to date) | −17% |
| 2025 | −48% |
| 2024 | −46% |
| 2023 | +43% |
| 2022 | −74% |
| 2021 | −20% |
| 2020 | −16% |
| 2019 | +89% |
| 2018 | −79% |
| 2017 | −27% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 3 of 10 | +6.7% |
| Feb | 10 | 5 of 10 | −1.8% |
| Mar | 10 | 4 of 10 | +7.4% |
| Apr | 10 | 7 of 10 | +0.43% |
| May | 10 | 3 of 10 | −4.1% |
| Jun | 10 | 3 of 10 | −7.5% |
| Jul | 11 | 4 of 11 | +0.54% |
| Aug | 11 | 6 of 11 | +4.1% |
| Sep | 11 | 3 of 11 | −4.4% |
| Oct | 11 | 1 of 11 | −9.7% |
| Nov | 10 | 7 of 10 | +8.3% |
| Dec | 10 | 3 of 10 | −7.5% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers, Specialty & Generic
The closest names by size in the same industry